Načítá se...
Identification of a small molecule yeast TORC1 inhibitor with a flow cytometry-based multiplex screen
TOR (target of rapamycin) is a serine/threonine kinase, evolutionarily conserved from yeast to human, which functions as a fundamental controller of cell growth. The moderate clinical benefit of rapamycin in mTOR-based therapy of many cancers favors the development of new TOR inhibitors. Here we rep...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3331904/ https://ncbi.nlm.nih.gov/pubmed/22260433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cb200452r |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|